Liver Fibrosis Drug Market size is estimated to be USD 4.5 Billion in 2024 and is expected to reach USD 10.2 Billion by 2033 at a CAGR of 9.8% from 2026 to 2033.
In 2021, the therapeutic market for liver fibrosis associated with non alcoholic steatohepatitis (NASH) in the seven major markets (7MM) was valued at approximately USD 2,225 million. The United States accounted for about 79% of this market, equating to roughly USD 1,758 million. Among the European Unions five largest economies (EU5), Germany led with a market size of USD 94 million, while Spain had the smallest at USD 55 million. Japans market was estimated at USD 108 million, representing 5% of the total 7MM market. In the Asia Pacific region, Chinas liver fibrosis market was valued at USD 1.42 billion in 2022 and is projected to reach USD 3.44 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. Indias market was valued at USD 1.09 billion in 2022, with expectations to reach USD 2.6 billion by 2030, reflecting a CAGR of 11.6% during the same period. Conversely, the global liver fibrosis drug market was valued at USD 12,290 million in 2022 and is projected to decline to USD 10,950 million by 2029, indicating a negative CAGR of 1.6% over the forecast period.
Get | Download Sample Copy with TOC, Graphs & List of Figures @ http://verifiedmarketreports.com/download-sample/?rid=863688&utm_source=Google site_G_April&utm_medium=235
Gilead
Biogen Idec
Merck KGaA
Bristol-Myers Squibb Company
Roche
Merck & Co.
Inc Tri-Prime
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=863688&utm_source=Google site_G_April&utm_medium=235
Growing demand for below applications around the world has had a direct impact on the growth of the Global Liver Fibrosis Drug Market
Antiviral Agents
Anti-inflammatory Drugs
Hepatoprotective Agents
Antifibrotic Agents
Immunomodulators
Oral
Injectable
Intravenous
Topical
Non-Alcoholic Fatty Liver Disease (NAFLD)
Alcoholic Liver Disease (ALD)
Chronic Viral Hepatitis
Autoimmune Hepatitis
Hemochromatosis
Stage 1: Mild Fibrosis
Stage 2: Moderate Fibrosis
Stage 3: Severe Fibrosis
Stage 4: Cirrhosis
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Direct Sales
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ https://www.verifiedmarketreports.com/product/liver-fibrosis-drug-market/
1. Introduction of the Global Liver Fibrosis Drug Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Liver Fibrosis Drug Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Liver Fibrosis Drug Market, By Type
6. Global Liver Fibrosis Drug Market, By Application
7. Global Liver Fibrosis Drug Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Global Liver Fibrosis Drug Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/